Novartis
NVS
$97.11
Share price
0.89%
Change (1 day)
6.78%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
Novartis (NVS) - P/B ratio
P/B ratio as of June 2023 : 3.95
According to Novartis's latest financial reports the company has a price-to-book ratio of 3.95.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Novartis - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 3.28 | 13.36% |
| 2021-12-31 | 2.90 | -24.62% |
| 2020-12-31 | 3.84 | -0.63% |
| 2019-12-31 | 3.87 | 54.26% |
| 2018-12-31 | 2.51 | -5.63% |
| 2017-12-31 | 2.66 | 15.01% |
| 2016-12-31 | 2.31 | -14.55% |
| 2015-12-31 | 2.70 | -14.52% |
| 2014-12-31 | 3.16 | 20.99% |
| 2013-12-31 | 2.61 | 18.76% |
| 2012-12-31 | 2.20 | 5.09% |
| 2011-12-31 | 2.09 | 8.56% |
| 2010-12-31 | 1.93 | -11.35% |
| 2009-12-31 | 2.18 | -2.62% |
| 2008-12-31 | 2.23 | -10.26% |
| 2007-12-31 | 2.49 | -23.78% |
| 2006-12-31 | 3.27 | -11.63% |
| 2005-12-31 | 3.70 | 2.23% |
| 2004-12-31 | 3.62 | -2.56% |
| 2003-12-31 | 3.71 | 15.97% |
| 2002-12-31 | 3.20 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.23 | 32.47% | 🇺🇸 USA |
 Pfizer PFE | 2.24 | -43.30% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.84 | 22.72% | 🇺🇸 USA |
 Sanofi SNY | 1.57 | -60.33% | 🇫🇷 France |
 Merck MRK | 6.11 | 54.86% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 4.26 | 7.95% | 🇺🇸 USA |
 AstraZeneca AZN | 6.40 | 62.26% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 4.98 | 26.12% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 0.9546 | -75.82% | 🇮🇱 Israel |